发明名称 |
ASPARTIC PROTEASE INHIBITORS |
摘要 |
The present invention provides a compound of formula (I) wherein a, b, c, d, and e, are R<7>, OR<7>, SR<7>, NR<7>R<8>, NHCOR<7>, CO2R<7>, CN, NO2, NH2, N3, or a halogen. R<7> and R<8> are H or alkyl, R<1> and R<2> are H or alkyl, and R<3> is a non-aromatic substituent. Substituent A is OH, NH2, or SH. Substituents B and B<1> include amide and sulfonamide groups, which can be cyclic, acyclic, or amino acid derivatives. Alternatively, B and R' together with the nitrogen to which they are bonded, and/or B' and R<2> together with the nitrogen to which they are bonded, define a heterocycle. The present invention further provides a pharmaceutical composition that includes a carrier and a therapeutically effective amount of at least one compound of the present invention. The present invention further provides therapeutic methods that include administering a therapeutically effective amount of at least one compound of the present invention.
|
申请公布号 |
WO0040558(A1) |
申请公布日期 |
2000.07.13 |
申请号 |
WO2000US00265 |
申请日期 |
2000.01.06 |
申请人 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES;RANDAD, RAMNARAYAN, S.;ERICKSON, JOHN, W.;EISSENSTAT, MICHAEL, A.;LUBKOWSKA, LUCYNA |
发明人 |
RANDAD, RAMNARAYAN, S.;ERICKSON, JOHN, W.;EISSENSTAT, MICHAEL, A.;LUBKOWSKA, LUCYNA |
分类号 |
A61P31/18;C07C235/20;C07C235/50;C07C237/34;C07C271/20;C07C271/22;C07C311/29;C07D207/26;C07D207/27;C07D211/60;C07D213/30;C07D215/48;C07D239/10;C07D277/24;C07D295/215;C07D307/20;C07D405/12;C07D417/12;(IPC1-7):C07D213/56;C07D295/20;C07D295/16;C07D277/20;C07D265/32;A61K31/44;A61K31/425;A61K31/335 |
主分类号 |
A61P31/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|